Ellen is an early career research commercialisation professional who is driven by a desire to develop new medicines and improve patient outcomes. She comes from a research background in synthetic medicinal chemsitry and molecular biology, which assists her in supporting the development fo various therapeutics and biotechnologies. She has previously supported the commercialisation of IP for medical technologies arising from CALHN, including from the Royal Adelaide Hospital, The Queen Elizabeth Hospital and SA Pathology.
If you consent to the use of our cookies then please click the button below:
If you do not consent to the use of all our cookies then please click the button below. Clicking this button will result in all cookies being rejected except for those that are required for essential functionality on our website.